Challenges of general safety evaluations of biologics compared to small molecule pharmaceuticals in animal models

Author： Dixit Rakesh Iciek Laurie A McKeever Kathleen Ryan Patricia Clare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.5, Iss.1, 2010-01, pp. : 79-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Invasive Tests in Animal Models and Humans: A New Paradigm for Assessing Efficacy of Biologics Including Prebiotics and Probiotics

Current Pharmaceutical Design, Vol. 14, Iss. 14, 2008-05 ,pp. : 1341-1350

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Design and Synthesis of Carbon-14 Labelled Pharmaceuticals from Small Molecule Precursors

Current Pharmaceutical Design, Vol. 6, Iss. 10, 2000-07 ,pp. : 1057-1083

Bentham Science Publishers

Access to resources Recommend Favorite

A Proposed Design for Conducting Target Animal Safety Studies for Developing New Veterinary Pharmaceuticals

By Carakostas M.C. Colaianne J.J.

Regulatory Toxicology and Pharmacology, Vol. 23, Iss. 1, 1996-02 ,pp. : 49-54

Academic Press

Access to resources Recommend Favorite

Biologics Safety Preclinical, Clinical and Regulatory

By Hennig Renald

Expert Opinion on Drug Safety, Vol. 2, Iss. 6, 2003-11 ,pp. : 609-611

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Antagonists of the Tachykinin NK2 Receptor [General Reviews]

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : 331-340

Bentham Science Publishers

Access to resources Recommend Favorite